Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:718 (1 October), doi:10.1136/bmj.331.7519.718
Lynn Eaton
London
Richard Feachem of the Global Fund to Fight AIDS, Tuberculosis, and Malaria tells Lynn Eaton how the fund sees the enforcement of transparency and accountability as a vital step in ensuring results
| The first 150 words of the full text of this article appear below. |
The recent decision by the Global Fund to Fight AIDS, Tuberculosis, and Malaria to suspend grants to Uganda on the grounds that the funds were misappropriated (
BMJ
2005;331: 475
Whether corruption is any worse in an African country than, say, in India or El Salvador, is open to debate. But how do aid agencies ensure that their funds are used for the purposes for which they are intended? And, from a medical viewpoint, what are the ramifications for public health if a funding organisation takes the difficult decision to suspend a grant?
Dr Richard Feachem, executive director of the fund, fully accepts the difficulty of what he described as the "life and death" decision they had to make over Uganda. The grants were worth a total of $201m
-->
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?